Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metabolic myopathies.

R L Wortmann1

  • 1Medical College of Wisconsin, Milwaukee.

Current Opinion in Rheumatology
|December 1, 1991
PubMed
Summary
This summary is machine-generated.

Metabolic myopathies disrupt muscle energy, causing dysfunction due to defects in glycogen, lipid, purine, or mitochondrial biochemistry. This review covers muscle metabolism, specific diseases, and diagnostic techniques.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advances in the management of gout and hyperuricaemia.

Scandinavian journal of rheumatology·2006
Same author

Polymyositis: an overdiagnosed entity.

Neurology·2004
Same author

The clinical laboratory evaluation of the patient with noninflammatory myopathy.

Current rheumatology reports·2001
Same author

Metabolic and mitochondrial myopathies.

Current opinion in rheumatology·1999
Same author

Effective management of gout: an analogy.

The American journal of medicine·1998
Same author

The clinical philosophy of internal medicine.

The American journal of medicine·1998
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Area of Science:

  • Biochemistry
  • Muscle Physiology
  • Genetics

Background:

  • Metabolic myopathies are a diverse group of disorders characterized by impaired muscle energy metabolism.
  • These conditions often stem from inborn errors of metabolism, affecting muscle fiber ATP production.
  • Traditionally, they are classified based on biochemical pathways: glycogen, lipid, purine, and mitochondrial.

Purpose of the Study:

  • To review the fundamental metabolic pathways essential for normal muscle function.
  • To discuss recent findings concerning glycogen storage diseases, carnitine deficiencies, and myoadenylate deaminase deficiencies.
  • To highlight emerging diagnostic techniques for evaluating myopathic disorders.

Main Methods:

  • Literature review of basic muscle metabolic pathways.

Related Experiment Videos

  • Analysis of recent research on specific metabolic myopathies (glycogen, lipid, purine, mitochondrial).
  • Overview of current and novel diagnostic methodologies for myopathic conditions.

    • Main Results:

    • Normal muscle function relies on intricate metabolic pathways for energy production.
    • Specific conditions like glycogen storage diseases and carnitine deficiencies present distinct metabolic challenges.
    • Advancements in diagnostic tools are improving the assessment of patients with metabolic myopathies.

    Conclusions:

    • Understanding muscle energy metabolism is crucial for diagnosing and managing metabolic myopathies.
    • Further research into these inborn errors of metabolism can lead to improved therapeutic strategies.
    • The integration of new diagnostic techniques enhances the characterization and clinical management of skeletal muscle dysfunction.